Sponsor
The Second Affiliated Hospital of Chongqing Medical University
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name The Second Affiliated Hospital of Chongqing Medical University appears in 31 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
31 shownFunctional Lung Avoidance Radiotherapy Guided by 4DCT Pulmonary Ventilation Function Imaging: A Prospective Single-arm Clinical StudyNCT07339644 · lead sponsor · 2025-10-24
RECRUITINGBody-weight Reduction Effect on Portal Hypertension in Compensated CirrhosisNCT07797101 · lead sponsor · 2026-09-01
NOT_YET_RECRUITINGRenal Sympathetic Denervation Combined With Aorticorenal Ganglion Ablation for Treatment of HypertensionNCT06864962 · lead sponsor · 2025-03-01
WITHDRAWNApplication of 4DCT-Based Pulmonary Ventilation Imaging in Lung Cancer RadiotherapyNCT07312682 · lead sponsor · 2024-12-09
ACTIVE_NOT_RECRUITINGEffects of Atomized Dexmedetomidine on Lung Function in Patients With Chronic Obstructive Pulmonary DiseaseNCT06207331 · lead sponsor · 2023-10-28
TERMINATEDEffect of Dexmedetomidine on Lung Protection in Elderly Patients Undergoing Laparoscopic Surgery for Colorectal CancerNCT07385898 · lead sponsor · 2023-04-17
COMPLETEDA Cohort Study on the Clinical Characteristics and Prognosis of HIV/AIDS Patients Infected With SARS-CoV-2NCT06172816 · lead sponsor · 2023-01-01
UNKNOWNLeft Atrial Enlargement: A Crucial Indicator for Identifying Atrial Fibrillation in Patients With HypertensionNCT06359873 · lead sponsor · 2022-05-01
COMPLETEDSafety and Immune Response of COVID-19 Vaccination in Patients With HIV InfectionNCT05043129 · lead sponsor · 2021-09-04
UNKNOWNSafety and Immune Response of COVID-19 Vaccination in Patients With Basic DiseaseNCT05043246 · lead sponsor · 2021-08-01
UNKNOWNSympathetic Mapping/ Ablation of Renal Nerves Trial (SMART) HTN-OFF MED StudyNCT03885843 · lead sponsor · 2019-06-01
UNKNOWNIntravascular Ultrasound Evaluation of Renal Nerves in Different DiseasesNCT02243514 · lead sponsor · 2014-10-01
UNKNOWNRenal Sympathetic Modification in Patients With Essential HypertensionNCT01417221 · lead sponsor · 2011-08-01
UNKNOWNRenal Sympathetic Modification in Patients With Heart FailureNCT01402726 · lead sponsor · 2011-07-01
UNKNOWNFull Length Versus Proximal Renal Arteries AblationNCT01848275 · lead sponsor · 2011-03-01
COMPLETEDNifedipine vs Telmisartan on Prevention of Atrial Fibrillation (AF) Recurrence in Hypertensive Patients With AFNCT01435161 · lead sponsor · 2007-05-01
COMPLETEDStudy on Human Bioequivalence of Triprerelin Acetate for InjectionNCT06683066 · collaborator · 2024-12-04
RECRUITINGThe Chinese Familial Alzheimer's NetworkNCT03657732 · collaborator · 2005-01-10
RECRUITINGChina Cognition and Aging StudyNCT03653156 · collaborator · 2000-01-01
RECRUITINGClinical Trial to Evaluate the Effectiveness of Liver Shear Wave Quantization Detector Spleen Stiffness Value in the Diagnosis of Esophageal VaricesNCT07753577 · collaborator · 2026-08-20
NOT_YET_RECRUITINGUnderdilated VCX-TIPS Versus EVL Plus NSBB for Secondary Prophylaxis of Variceal Bleeding in CirrhosisNCT07587671 · collaborator · 2026-08-01
NOT_YET_RECRUITINGEfficacy and Safety of Early Initiation of Vericiguat in Heart Failure After Acute Myocardial InfarctionNCT06812546 · collaborator · 2025-04-01
NOT_YET_RECRUITINGSacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic NephropathyNCT06501651 · collaborator · 2024-08-01
UNKNOWNThe Safety and Efficacy of Carotid Body Modulation Therapy in Hypertensive Patients by External Ultrasonic Micro-bubbleNCT06116357 · collaborator · 2023-12-01
NOT_YET_RECRUITINGMultimodal Magnetic Resonance Imaging-based Study of Electroconvulsive Efficacy Prediction in Adolescents With Depression: a Multicenter Prospective Cohort StudyNCT05889234 · collaborator · 2023-11-06
UNKNOWNFirst-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon MutationNCT05548348 · collaborator · 2022-09-26
UNKNOWNBioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese PatientsNCT05273944 · collaborator · 2021-07-28
UNKNOWNSafety and Efficacy of Pulmonary Artery Denervation in Patients With Pulmonary Arterial HypertensionNCT03282266 · collaborator · 2018-01-18
COMPLETEDRadiomics-based Surrogate of Endoscopy (rEndosc) (CHESS1703)NCT03373123 · collaborator · 2017-12-18
WITHDRAWNPredictive Effect of Abdominal Fat and Muscle Area Calculated Based on Abdominal CT on Gastric Cancer PatientsNCT06606912 · collaborator · 2012-01-01
UNKNOWNPredictive Effect of Abdominal Fat and Muscle Area Calculated Based on Abdominal CT on Colorectal Cancer PatientsNCT06614699 · collaborator · 2012-01-01
UNKNOWNDrugs studied in this sponsor's trials
4 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing The Second Affiliated Hospital of Chongqing Medical University as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
dexmedetomidine1
telmisartan1
valsartan1
vericiguat1
dexmedetomidine RxCUI 48937 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
telmisartan RxCUI 73494 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
valsartan RxCUI 69749 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
vericiguat RxCUI 2475830 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
Sponsor roles
lead sponsor16
collaborator15
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.